Brief: Sellas Announces Positive Initial Topline Phase 2a Data Of SLS009 In Acute Myeloid Leukemia

Sellas Life Sciences

16/10/2023 14:26

Oct 16 (Reuters) - Sellas Life Sciences Group Inc
 SLS.O :
    * SELLAS ANNOUNCES POSITIVE INITIAL TOPLINE PHASE 2A DATA OF
SLS009 IN ACUTE MYELOID LEUKEMIA
    * SELLAS LIFE SCIENCES GROUP INC - NO SIGNIFICANT SAFETY
ISSUES
OBSERVED
    * SELLAS LIFE SCIENCES GROUP INC - ANTI-LEUKEMIC EFFECTS
OBSERVED
IN ALL PATIENTS
    * SELLAS LIFE SCIENCES GROUP: FIRST PATIENT ENROLLED IN
STUDY
ACHIEVED COMPLETE RESPONSE, REMAINS ALIVE AND IS CURRENTLY IN
FIFTH MONTH OF TREATMENT

Source text for Eikon:  ID:nGNX3C61Dm 
Further company coverage:  SLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))